Categories
All News Analysis Forecast Coronavirus COVID-19 Market Impact Energy Growth Prospects Industry Analytics Market Outlook Market Price Analysis Market Reports

Interventional Oncology Market to Achieve Significant Growth in the coming Years

Global Interventional Oncology Market report it provides a vital recent industry data which covers in general market situation along with future scenario for industry around the Globe. It also consists of major data along with forecasts of a global market along with clear presentation of diagrams (charts and tables).

According to a new report published by Allied Market Research, titled, “Interventional Oncology Market by Procedure (Radiation Therapy [Internal and External Radiation Therapy], Ablation [Cryoablation Therapy, Microwave Ablation Therapy, and Radiofrequency Ablation], Particle Embolization [Drug-Eluting Beads, Radioembolization, Microspheres, and Polyvinyl Alcohol Particles]) – Global Opportunity Analysis and Industry Forecast, 2020-2027”

The Global market size of Interventional Oncology Market is $XX million in 2019 and it is expected to reach $XX million by the end of 2027 with a CAGR of XX% from 2020 to 2027.

 

Download PDF Report Sample with statistical info @  https://www.alliedmarketresearch.com/request-sample/3702

 

Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Comprehensive competitive analysis and profiles of major market players such as Boston Scientific, Accuray, Medtronic, AtriCure, Baylis Medical, BTG, Alpinion Medical Systems, Terumo Corporation, AngioDynamics, and Merit Medical have also been provided in this report.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/3702

 

Key Benefits

  • The study provides an in-depth analysis of the market along with current trends and future estimations to elucidate the imminent investment pockets.
  • Extensive analysis of the market is conducted by following key product positioning and monitoring the top competitors within the market framework.
  • It offers a quantitative analysis to enable the stakeholders to capitalize on the prevailing market opportunities.
  • Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
  • Key players are profiled and their strategies are analyzed thoroughly to understand the competitive outlook of the global market.

Interventional Oncology Market Key Segments:

By Procedure

  • Radiation Therapy
    • Internal Radiation Therapy
    • External Radiation Therapy
  • Ablation
    • Cryoablation Therapy
    • Microwave Ablation Therapy
    • Radiofrequency Ablation
  • Particle Embolization
    • Drug-Eluting Beads
    • Radioembolization
    • Microspheres
    • Polyvinyl Alcohol Particles

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Taiwan
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Turkey
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

 

Categories
Industry Analytics Market Reports World

Interventional Oncology Market Detailed Analysis 2019-2024: Medtronic, Boston Scientific, BTG plc, Merit Medical Systems, Terumo and Others.

The research reports on “Interventional Oncology Market” report gives detailed overview of factors that affect global business scope. Interventional Oncology Market report shows the latest market insights with upcoming trends and breakdowns of products and services. This report provides statistics on the market situation, size, regions and growth factors.

Need a Free Sample Report? Visit: https://www.reportsnreports.com/contacts/requestsample.aspx?name=2029743

The Global Interventional Oncology Market is projected to reach USD 2.9 Billion by 2024 from USD 2.0 Billion in 2019, at a CAGR of 6.8% from 2019 to 2024.

Top Companies Profiled in the Interventional Oncology Market:

  • Medtronic -Ireland
  • Boston Scientific -US
  • BTG plc -UK
  • Merit Medical Systems -US
  • Terumo-Japan

On the basis of procedure, the interventional oncology market is segmented into thermal tumor ablation, non-thermal tumor ablation, transcatheter arterial chemoembolization TACE, transcatheter arterial radioembolization TARE or selective internal radiation therapy SIRT, and transcatheter arterial embolization TAE or bland embolization procedures.

Based on cancer type, the interventional oncology market is segmented into liver cancer, lung cancer, kidney cancer, bone cancer, and other cancers. The other cancers segment includes pediatric cancer, prostate cancer, and breast cancer. The liver cancer segment accounted for the largest share in the interventional oncology market in 2018.

Go For Interesting Discount Here: https://www.reportsnreports.com/purchase.aspx?name=2029743

List of Tables:

Table 1 Interventional Oncology Market, By Product, 2017–2024 (USD Million)

Table 2 Recent Product Launches and Approvals of Embolization Devices

Table 3 Interventional Oncology Embolization Devices Market, By Type, 2017–2024 (USD Million)

Table 4 Interventional Oncology Embolization Devices Market, By Region, 2017–2024 (USD Million)

Table 5 Interventional Oncology Embolization Devices Market, By Procedure, 2017–2024 (USD Million)

Table 6 Interventional Oncology Embolization Devices Market, By Cancer Type, 2017–2024 (USD Million)

Table 7 Radioembolic Agents Offered By Major Market Players

Table 8 Radioembolic Agents Market, By Region, 2017–2024 (USD Million)

Table 9 Radioembolic Agents Market, By Procedure, 2017–2024 (USD Million)

Table 10 Radioembolic Agents Market, By Cancer Type, 2017–2024 (USD Million)

Table 11 Non-Radioactive Embolic Agents Offered By Major Market Players

Table 12 Non-Radioactive Embolic Agents Market, By Region, 2017–2024 (USD Million)

Table 13 Non-Radioactive Embolic Agents Market, By Procedure, 2017–2024 (USD Million)

Table 14 Non-Radioactive Embolic Agents Market, By Cancer Type, 2017–2024 (USD Million)

Table 15 Interventional Oncology Ablation Devices Market, By Type, 2017–2024 (USD Million)

Table 16 Interventional Oncology Ablation Devices Market, By Region, 2017–2024 (USD Million)

Table 17 Interventional Oncology Ablation Devices Market, By Procedure, 2017–2024 (USD Million)

Table 18 Interventional Oncology Ablation Devices Market, By Cancer Type, 2017–2024 (USD Million)

Table 19 Radiofrequency Ablation Devices Offered By Major Market Players

Table 20 Radiofrequency Ablation Devices Market, By Region, 2017–2024 (USD Million)

Table 21 Radiofrequency Ablation Devices Market, By Procedure, 2017–2024 (USD Million)

Table 22 Radiofrequency Ablation Devices Market, By Cancer Type, 2017–2024 (USD Million)

Table 23 Microwave Ablation Devices Market, By Region, 2017–2024 (USD Million)

Table 24 Microwave Ablation Devices Market, By Procedure, 2017–2024 (USD Million)

Table 25 Microwave Ablation Devices Market, By Cancer Type, 2017–2024 (USD Million)

Table 26 Cryoablation Devices Market, By Region, 2017–2024 (USD Million)

Table 27 Cryoablation Devices Market, By Procedure, 2017–2024 (USD Million)

Table 28 Cryoablation Devices Market, By Cancer Type, 2017–2024 (USD Million)

Table 29 Other Ablation Devices Market, By Region, 2017–2024 (USD Million)

Table 30 Other Ablation Devices Market, By Procedure, 2017–2024 (USD Million)

…..And More

Reason to access this report:

This report focuses on various levels of analysis—industry trends, market shares of top players, and company profiles, which together form basic views. It also analyzes the competitive landscape; emerging segments of the interventional oncology market; and high-growth regions and their drivers, restraints, challenges, and opportunities.

Do you have any query or specific requirement? Ask to our industry expert at  https://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=2029743